ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1776

Causal Effect of TNF-α, IL-12p70, IL-17 Levels on the Risk of Psoriatic Arthritis: A Mendelian Randomization Study

Dongze WU1, Priscilla Wong 1, Steven H.M. Lam 1, Isaac T. Cheng 1, Edmund K. Li 1, Ling Qin 1 and Lai-Shan Tam 1, 1The Chinese University of Hong Kong, Hong Kong, Hong Kong

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: interleukins (IL), polymorphism and psoriasis, Psoriatic arthritis, Tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M095: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1776–1781)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Biologic agents targeting cytokines including TNF-α, IL-12p70 and IL-17 have been proven to be very effective in treating psoriatic arthritis (PsA).  Nonetheless, whether these cytokines are causally associated with PsA is uncertain. The study aims to compare causal associations between genetically predicted cytokine level and risk of psoriatic arthritis via a two-sample Mendelian Randomization approach.

Methods: We used the publicly available summary-level findings from genome-wide association studies (GWAS) for identification of loci influencing concentrations of circulating cytokines (PMID: 27989323, n=8 293) as exposure and a GWAS for non-cancer illness code self-reported: PsA from the individuals included in the UK Biobank (total n = 462 933; case = 900, control = 462 033) as the outcome. A two-sample Mendelian randomization (MR) analysis was performed using the inverse-variance weighted (IVW), weighted median, and MR-Egger regression methods. Sensitivity analysis and MR-Egger regression analysis were performed to evaluate the heterogeneity and pleiotropic effects of each variant.

Results: Single-nucleotide polymorphisms (SNPs) at genome-wide significance from GWASs on TNF-α (6 and 3 SNPs for increased and decreased TNF-α levels respectively), IL-12p70 (9 and 5 SNPs for increased and decreased in IL-12p70 levels respectively), IL-17 (7 and 5 SNPs for increased and decreased IL-17 levels respectively) were identified as the instrumental variables (IVs).    Our results provided evidence to support a causal association between elevated level of Il-17 (IVs: rs117556572, rs141312283, rs149738638, rs17282552, rs187475560, rs57920188, rs62191444) and PsA (MR Egger, p = 0.087; Weighted median: p=0.014; Inverse variance weighted: p= 0.002).  All three methods did not show any causal association between PsA and increased and decreased TNF-α and IL-12p70, and decreased IL-17 level (Table 1).  Cochran’s Q test and the funnel plot indicated no evidence of heterogeneity and asymmetry, indicating no directional pleiotropy.

Conclusion: Our findings provided strong evidence on the causal association of genetically elevated circulating IL-17 levels with the risk of developing psoriatic arthritis. IL-17 blockade might prevent the transition from psoriasis to psoriatic arthritis that warrants testing in suitably powered randomized trials.


Abstract_ACR 2019_table


Disclosure: D. WU, None; P. Wong, None; S. Lam, None; I. Cheng, None; E. Li, None; L. Qin, None; L. Tam, None.

To cite this abstract in AMA style:

WU D, Wong P, Lam S, Cheng I, Li E, Qin L, Tam L. Causal Effect of TNF-α, IL-12p70, IL-17 Levels on the Risk of Psoriatic Arthritis: A Mendelian Randomization Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/causal-effect-of-tnf-%ce%b1-il-12p70-il-17-levels-on-the-risk-of-psoriatic-arthritis-a-mendelian-randomization-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/causal-effect-of-tnf-%ce%b1-il-12p70-il-17-levels-on-the-risk-of-psoriatic-arthritis-a-mendelian-randomization-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology